SAN FRANCISCO (MarketWatch) -- Roche and GlaxoSmithKline Plc said late Friday the Food and Drug Administration has approved Boniva Injection, the first intravenous medication for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback